Observational studyMedicine2021

Serum IL-6 and procalcitonin are two promising novel biomarkers for evaluating the severity of COVID-19 patients.

Jinsong Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.